Details of the Drug

General Information of Drug (ID: DMQMCFJ)

Drug Name

CPK850

Indication

Disease Entry	ICD 11	Status	REF
Retinitis pigmentosa	9B70	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03374657) A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa. U.S. National Institutes of Health.